During 2009, an estimated 200,000 Hospital Acquired Infections (HAI), at a prevalence rate of 6 to 8 per cent, were reported by the Australian Commission of Safety and Quality in Healthcare (ACSQHC). Being a developed nation, the incidence rates of HAI are higher and hence a coordinated nation-wide approach for the prevention and control of HAI was considered a priority to ensure patient safety and reduce the huge strain on the health system. Currently, there is no systematic Australia-wide approach to the measurement of patient harm caused by or associated with HAI.
New analysis from Frost & Sullivan (medicaldevices.frost.com), Hospital-acquired Infection Incidence - Trends in Australia, finds that an estimated two million bed days are lost due to HAI and this is likely to reduce by 2015 as a result of the measures initiated by the government to prevent infections.
"Different practices and guidelines are followed in each state as there are no national guidelines or standard definitions," says Frost & Sullivan Consultant Poornima Srinivasan. "Although standard surveillance is available for HAI, there is no national coordinating agency or commission like the National Nosocomial Infections Surveillance System in the United States."
However, the Government of Australia is coming up with measures of mandatory reporting and transparency in reporting HAI by both public and private hospitals.
"As the government comes up with guidelines and protocols for prevention and control of infections, industry participants in the infection control market comprising disinfectants, gels, and scrubs can utilise the opportunity to establish their presence in the market," says Srinivasan. "This can be accomplished by working together with the health services and influencers in the market."
As a result of the recent initiatives on hand hygiene measures, the use of hand rub has already increased drastically in hospitals over the last two years. With the establishment of ACSQHC and the initiatives on hand hygiene, most hospitals had significant reduction in methicillin-resistant staphylococcus aureus (MRSA) rates as well.
Going forward, Australia is expected to experience a drastic reduction in infection rates between 2013 and 2015 due to measures taken by ACSQHC and national streamlining with proper definition, surveillance, reporting and feedback measures.
If you are interested in more information on this study, please send an email to Donna Jeremiah, Corporate Communications, at djeremiah[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country.
Hospital-acquired Infection Incidence - Trends in Australia is part of the Medical Devices Growth Partnership Service program. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.
Hospital-acquired Infection Incidence - Trends in Australia / P533